These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14557731)

  • 1. Treating nicotine dependence.
    Glover ED; Glover PN; Payne TJ
    Am J Med Sci; 2003 Oct; 326(4):183-6. PubMed ID: 14557731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatments for the nicotine dependent smoker.
    Glover ED; Glover PN
    Am J Health Behav; 2001; 25(3):179-82. PubMed ID: 11322615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating nicotine dependence.
    Glover ED; Glover PN
    W V Med J; 2001; 97(1):39-43. PubMed ID: 11257836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine dependence. Interface between tobacco and tobacco-related disease.
    Henningfield JE; Nemeth-Coslett R
    Chest; 1988 Feb; 93(2 Suppl):37S-55S. PubMed ID: 3276461
    [No Abstract]   [Full Text] [Related]  

  • 6. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharmacotherapies.
    Saxon AJ; Baer JS; Davis TM; Sloan KL; Malte CA; Fitzgibbons K; Kivlahan DR
    Nicotine Tob Res; 2003 Aug; 5(4):589-96. PubMed ID: 12959797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate of nicotine metabolism and smoking cessation outcomes in a community-based sample of treatment-seeking smokers.
    Kaufmann A; Hitsman B; Goelz PM; Veluz-Wilkins A; Blazekovic S; Powers L; Leone FT; Gariti P; Tyndale RF; Schnoll RA
    Addict Behav; 2015 Dec; 51():93-9. PubMed ID: 26240944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.
    Watkins SS; Koob GF; Markou A
    Nicotine Tob Res; 2000 Feb; 2(1):19-37. PubMed ID: 11072438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of bupropion in the management of smoking cessation.
    Jorenby D
    Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery.
    Smolka MN; Bühler M; Klein S; Zimmermann U; Mann K; Heinz A; Braus DF
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):577-88. PubMed ID: 16133128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of nicotine dependence. Is more better?
    Hughes JR
    JAMA; 1995 Nov; 274(17):1390-1. PubMed ID: 7563566
    [No Abstract]   [Full Text] [Related]  

  • 12. Rodent models of nicotine withdrawal syndrome.
    Malin DH; Goyarzu P
    Handb Exp Pharmacol; 2009; (192):401-34. PubMed ID: 19184657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nicotine dependence--medico-biological aspects].
    Dybing E; Sanner T
    Tidsskr Nor Laegeforen; 2002 Jan; 122(3):302-5. PubMed ID: 11894603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smokeless tobacco: an addicting drug.
    Henningfield JE; Fant RV; Tomar SL
    Adv Dent Res; 1997 Sep; 11(3):330-5. PubMed ID: 9524433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating nicotine addiction.
    Jain A
    BMJ; 2003 Dec; 327(7428):1394-5. PubMed ID: 14670889
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drugs used to treat nicotine addiction].
    Zieleń I; Sliwińska-Mossoń M; Milnerowicz H
    Przegl Lek; 2012; 69(10):1098-102. PubMed ID: 23421099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A tragic triad: coronary artery disease, nicotine addiction, and depression.
    Thorndike AN; Rigotti NA
    Curr Opin Cardiol; 2009 Sep; 24(5):447-53. PubMed ID: 19550307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous cannabinoid and opioid systems and their role in nicotine addiction.
    Maldonado R; Berrendero F
    Curr Drug Targets; 2010 Apr; 11(4):440-9. PubMed ID: 20017727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen as a therapy for reducing nicotine withdrawal symptoms.
    Granger RH
    Med Hypotheses; 2005; 65(6):1161-4. PubMed ID: 16002232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.